CFTR and asthma in the French EGEA study

European Journal of Human Genetics

Volumn 9, Issue 1, 2001, Pages 67-69

  De Cid, Rafael ^a   Chomel, Jean Claude ^b   Lazaro, Conxi ^a   Sunyer, Jordi ^c   Baudis, Marlene ^b   Casals, Teresa ^a   Le Moual, Nicole ^d   Kitzis, Alain ^b   Feingold, Josue ^d   Anto, Josep ^c,e   Estivill, Xavier ^a   Kaufmann, Francine ^d  

^a Institut de Recerca Oncologica   (Spain)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d INSERM   (France)

^e UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; AGE; AGED; ASPERGILLUS; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CASE CONTROL STUDY; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTIC FIBROSIS; ENVIRONMENT; FEMALE; FRANCE; GEL ELECTROPHORESIS; GENDER; GENE MUTATION; GENETICS; HETEROZYGOSITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; PROTEIN VARIANT; RISK FACTOR; SPAIN; STANDARDIZATION; STATISTICS;

ADOLESCENT; ADULT; AGED; ASTHMA; CHILD; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; FRANCE; GENE FREQUENCY; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION;

ASPERGILLUS; BRONCHUS;

EID: 0035146725     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200578     Document Type: Letter

References (12)

1. ΔF508 heterozygosity in cystic fibrosis and susceptibility to asthma
2. Missense mutations in the cystic fibrosis gene in adult patients with asthma
3. Protection against bronchial asthma by CFTR Delta F508 mutation: A heterozygote advantage in cystic fibrosis
4. Epidemiological study on the genetics and environment of Asthma, bronchial hyperresponsiveness and atopy (EGEA) - Phenotype issues
5. Δ508 heterozygosity and asthma
6. The clinical centers of the CF French registry: Cystic fibrosis mutations report from the French registry
7. EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy) - Descriptive characteristics
8. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene
9. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
10. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene
11. Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions
12. Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma